NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
JPS5031249B1
(fr)
|
1970-12-17 |
1975-10-08 |
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
JPS5710876B2
(fr)
|
1974-04-08 |
1982-03-01 |
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
US4138498A
(en)
*
|
1976-12-07 |
1979-02-06 |
W. R. Grace & Co. |
Ruminant feed additive
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
JPS5557520A
(en)
|
1978-10-26 |
1980-04-28 |
Nisshin Flour Milling Co Ltd |
Preparation of carcinostatic substance
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
NL8300698A
(nl)
|
1983-02-24 |
1984-09-17 |
Univ Leiden |
Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
DK122686D0
(da)
|
1986-03-17 |
1986-03-17 |
Novo Industri As |
Fremstilling af proteiner
|
FR2613624B1
(fr)
|
1987-04-10 |
1990-11-23 |
Roussy Inst Gustave |
Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
WO1990001335A1
(fr)
|
1988-08-02 |
1990-02-22 |
Borody Thomas J |
Traitement de troubles gastro-intestinaux
|
KR100225087B1
(ko)
|
1990-03-23 |
1999-10-15 |
한스 발터라벤 |
피타아제의 식물내 발현
|
DE69107455T3
(de)
|
1990-05-09 |
2004-09-23 |
Novozymes A/S |
Eine ein endoglucanase enzym enthaltende zellulasezubereitung.
|
GB9107305D0
(en)
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
DE69316801T2
(de)
|
1992-07-20 |
1998-05-20 |
Yakult Honsha Kk |
Spezies-Spezifische Oligonukleotide gegen Bifidobakterien und Verfahren zum Nachweis unter Verwendung derselben
|
CA2151154C
(fr)
|
1992-12-10 |
1999-01-26 |
William E. Hintz |
Production de proteines heterologues dans des champignons filamenteux
|
US5741665A
(en)
|
1994-05-10 |
1998-04-21 |
University Of Hawaii |
Light-regulated promoters for production of heterologous proteins in filamentous fungi
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
AUPM823094A0
(en)
|
1994-09-16 |
1994-10-13 |
Goodman Fielder Limited |
Probiotic compositions
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
RU2078815C1
(ru)
|
1995-01-17 |
1997-05-10 |
Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского |
Штамм бактерий bifidobacterium breve, используемый для получения бактерийных лечебно-профилактических бифидосодержащих препаратов
|
JPH08259450A
(ja)
|
1995-03-17 |
1996-10-08 |
Nichinichi Seiyaku Kk |
インターフェロン産生増強剤
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
EP0952773B1
(fr)
*
|
1995-09-15 |
2005-11-23 |
Dale N. Gerding |
Procedes et compositions pour prevenir et traiter les maladies associees a clostridium difficile
|
AUPN698495A0
(en)
|
1995-12-06 |
1996-01-04 |
Pharma Pacific Pty Ltd |
Improved therapeutic formulation and method
|
SE508045C2
(sv)
|
1996-02-26 |
1998-08-17 |
Arla Ekonomisk Foerening |
Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
|
AUPN881396A0
(en)
|
1996-03-20 |
1996-04-18 |
Arnott's Biscuits Limited |
Enhancement of microbial colonization of the gastrointestinal tract
|
EP0901371B1
(fr)
|
1996-03-20 |
2008-09-10 |
The University Of New South Wales |
Modification apportee a des populations microbiennes dans le tractus gastro-intestinal
|
WO1997035956A1
(fr)
|
1996-03-27 |
1997-10-02 |
Novo Nordisk A/S |
Champignons filamenteux carences en proteases alcalines
|
US6033864A
(en)
|
1996-04-12 |
2000-03-07 |
The Regents Of The University Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
|
AU6773598A
(en)
|
1997-03-26 |
1998-10-20 |
Institut Pasteur |
Treatment of gastrointestinal disease with ppar modulators
|
SE511524C2
(sv)
|
1997-06-02 |
1999-10-11 |
Essum Ab |
Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
|
US5925657A
(en)
|
1997-06-18 |
1999-07-20 |
The General Hospital Corporation |
Use of PPARγ agonists for inhibition of inflammatory cytokine production
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
US6652866B1
(en)
|
1997-10-14 |
2003-11-25 |
David W. Hertha |
Method for treating diseases of fungal, yeast, and prion protein etiology
|
IT1298918B1
(it)
|
1998-02-20 |
2000-02-07 |
Mendes Srl |
Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
|
DE19826928A1
(de)
|
1998-06-17 |
1999-12-23 |
Novartis Consumer Health Gmbh |
Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
US7090973B1
(en)
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
AUPQ137699A0
(en)
*
|
1999-07-02 |
1999-07-22 |
University Of New England, The |
Control of acidosis
|
ES2204684T3
(es)
|
1999-08-27 |
2004-05-01 |
Eli Lilly And Company |
Derivados de biaril-oxa(tia)zol y su uso como modulares de ppar.
|
PL203212B1
(pl)
|
2000-02-08 |
2009-09-30 |
Dsm Ip Assets Bv |
Zastosowanie trwałej w kwasie proteazy w karmie zwierzęcej oraz w wytwarzaniu kompozycji do stosowania w karmie zwierzęcej, dodatek do karmy zwierzęcej, kompozycja karmy zwierzęcej i sposób obróbki białek roślinnych
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
US20020013270A1
(en)
*
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
WO2002042328A2
(fr)
|
2000-11-27 |
2002-05-30 |
Washington University |
Methode pour etudier l'effet d'une flore microbienne commensale sur l'intestin d'un mammifere, et traitement d'une maladie gastro-intestinale fonde sur cette methode
|
CA2431108A1
(fr)
*
|
2000-12-21 |
2002-06-27 |
Societe Des Produits Nestle S.A. |
Souche de lactobacille produisant une levane et son utilisation dans des produits alimentaires destines aux humains ou aux animaux domestiques
|
DE10101793A1
(de)
|
2001-01-17 |
2002-08-01 |
Manfred Nilius |
Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen
|
EP1227152A1
(fr)
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Souche bactérienne et genome de bifidobacterium
|
KR100437497B1
(ko)
|
2001-03-07 |
2004-06-25 |
주식회사 프로바이오닉 |
로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
|
EP1243273A1
(fr)
|
2001-03-22 |
2002-09-25 |
Societe Des Produits Nestle S.A. |
Composition contenant un agent prebiotique pour le traitement d'inflammation et d'activation anormal des agents immunitaires non-spécifiques
|
EP1389464A4
(fr)
|
2001-04-06 |
2005-06-22 |
Combi Co |
Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon
|
ATE463505T1
(de)
|
2001-04-20 |
2010-04-15 |
Inst Systems Biology |
Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
|
EP1260227A1
(fr)
|
2001-05-23 |
2002-11-27 |
Societe Des Produits Nestle S.A. |
L'acide lipoteichoique des bacteries lactiques et son utilisation pour moduler des responses immunitaites induites par des bacteries a gram negatif, gram positif
|
US20030092163A1
(en)
|
2001-07-26 |
2003-05-15 |
Collins John Kevin |
Probiotic bifidobacterium strains
|
MXPA04001999A
(es)
|
2001-09-05 |
2004-07-16 |
Vsl Pharmaceuticals Inc |
Bacterias de acido lactico que comprende dinucleotidos de citosina-guanina no metilados para usarse en terapia.
|
GB0127916D0
(en)
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
WO2003045317A2
(fr)
|
2001-11-27 |
2003-06-05 |
Washington University |
Proteine therapeutique et traitements
|
DK1581119T3
(da)
|
2001-12-17 |
2013-05-13 |
Corixa Corp |
Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
DE10206995B4
(de)
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
JP2003261453A
(ja)
|
2002-03-11 |
2003-09-16 |
Nippon Berumu Kk |
E.フェカリスからなる抗腫瘍剤及び放射線防護剤
|
DE60322570D1
(de)
|
2002-06-28 |
2008-09-11 |
Puleva Biotech Sa |
Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung
|
US20040005304A1
(en)
*
|
2002-07-08 |
2004-01-08 |
Mak Wood, Inc. |
Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
|
GB0307026D0
(en)
|
2003-03-27 |
2003-04-30 |
Rowett Res Inst |
Bacterial supplement
|
US20040230963A1
(en)
*
|
2003-05-12 |
2004-11-18 |
Rothman Michael A. |
Method for updating firmware in an operating system agnostic manner
|
EP1481681A1
(fr)
|
2003-05-30 |
2004-12-01 |
Claudio De Simone |
Combinaisons de bactéries lactiques et leur compositions
|
GB0316915D0
(en)
|
2003-07-18 |
2003-08-20 |
Glaxo Group Ltd |
Compounds
|
AU2003247193A1
(en)
|
2003-07-23 |
2005-02-04 |
M.D.Lab Corp. |
Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
|
US7485325B2
(en)
|
2003-08-06 |
2009-02-03 |
Gayle Dorothy Swain |
Animal food supplement compositions and methods of use
|
JP4683881B2
(ja)
|
2003-08-27 |
2011-05-18 |
有限会社アーク技研 |
抗腫瘍活性剤
|
US20070190022A1
(en)
|
2003-08-29 |
2007-08-16 |
Bacopoulos Nicholas G |
Combination methods of treating cancer
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US20050163764A1
(en)
|
2003-09-22 |
2005-07-28 |
Yale University |
Treatment with agonists of toll-like receptors
|
GB0323039D0
(en)
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
WO2005039319A2
(fr)
|
2003-10-24 |
2005-05-06 |
N.V. Nutricia |
Composition symbiotique pour nourrissons
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
RU2407784C2
(ru)
|
2003-12-17 |
2010-12-27 |
Н.В. Нютрисиа |
Пробиотический штамм lactobacillus casei, продуцирующий молочную кислоту, применение штамма для приготовления питательной композиции для лечения или профилактики легочной дисфункции, питательная композиция и способ ее получения, лекарственное средство для лечения или профилактики хронической обструктивной болезни легких у субъекта и применение штамма для приготовления лекарственного средства, контейнер
|
ES2235642B2
(es)
|
2003-12-18 |
2006-03-01 |
Gat Formulation Gmbh |
Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos.
|
WO2005093049A1
(fr)
|
2004-03-22 |
2005-10-06 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Inactivation cellulaire et virale
|
US20080248068A1
(en)
|
2004-05-07 |
2008-10-09 |
Hans-Gustaf Ljunggren |
Use of Flagellin as an Adjuvant for Vaccine
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
PL1765391T3
(pl)
|
2004-06-07 |
2013-08-30 |
Qu Biologics Inc |
Kompozycje bakteryjne do leczenia nowotworów
|
EP2279730A1
(fr)
|
2004-06-30 |
2011-02-02 |
Nutrition Sciences N.V./S.A. |
Acides gras à chaine moyenne comme agents antimicrobiens contre Enterococcus sp.
|
EP1629850B2
(fr)
|
2004-08-24 |
2013-05-22 |
N.V. Nutricia |
Composition nutritive comprenant des transgalactooligosaccharides indigestibles et des galactose saccharides digestibles
|
US20060062773A1
(en)
|
2004-09-21 |
2006-03-23 |
The Procter & Gamble Company |
Compositions for maintaining and restoring normal gastrointestinal flora
|
JP5371169B2
(ja)
|
2004-09-24 |
2013-12-18 |
コンビ株式会社 |
薬剤耐性菌感染防除剤
|
KR100468522B1
(ko)
|
2004-10-12 |
2005-01-31 |
주식회사 프로바이오닉 |
코로나바이러스와 돼지 써코바이러스 2형의 생육을 억제하는 신규한 내산성 프로바이오틱 엔테로코커스훼시움 프로바이오-63
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
ITMI20042189A1
(it)
|
2004-11-16 |
2005-02-16 |
Anidral Srl |
Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
|
AU2006217160B2
(en)
|
2005-02-28 |
2011-09-15 |
N.V. Nutricia |
Nutritional composition with probiotics
|
US20090233888A1
(en)
|
2005-03-23 |
2009-09-17 |
Usc Stevens, University Of Southern California |
Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
|
US20100048595A1
(en)
|
2005-03-23 |
2010-02-25 |
Washington University In St. Louis |
Use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota
|
JP2006265212A
(ja)
|
2005-03-25 |
2006-10-05 |
Institute Of Physical & Chemical Research |
Il−21産生誘導剤
|
US20100233312A9
(en)
|
2005-04-11 |
2010-09-16 |
The Procter & Gamble Company |
Compositions comprising probiotic and sweetener components
|
EP1714660A1
(fr)
|
2005-04-21 |
2006-10-25 |
N.V. Nutricia |
D'acide uronique et des probiotiques
|
US8603461B2
(en)
|
2005-04-26 |
2013-12-10 |
TEAGASC—The Agriculture and Food Development Authority |
Probiotic composition suitable for animals
|
PL2439273T3
(pl)
|
2005-05-09 |
2019-08-30 |
Ono Pharmaceutical Co., Ltd. |
Ludzkie przeciwciała monoklonalne przeciwko białku programowanej śmierci komórki 1(pd-1) oraz metody leczenia nowotworów z wykorzystaniem przeciwciał anty-pd-1 samodzielnie lub w połączeniu z innymi immunoterapeutykami
|
US7572474B2
(en)
|
2005-06-01 |
2009-08-11 |
Mead Johnson Nutrition Company |
Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
|
US8075934B2
(en)
|
2008-10-24 |
2011-12-13 |
Mead Johnson Nutrition Company |
Nutritional composition with improved digestibility
|
JP2007084533A
(ja)
|
2005-08-24 |
2007-04-05 |
Prima Meat Packers Ltd |
免疫応答調節組成物及び該組成物を有効成分とする食品
|
US7625704B2
(en)
|
2005-08-31 |
2009-12-01 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for identifying bacteria associated with bacteria vaginosis
|
EP1933869B1
(fr)
|
2005-09-01 |
2009-10-14 |
Schering Corporation |
Utilisation d'antagonistes de l'il-23 et de l'il-17 pour le traitement de la maladie inflammatoire oculaire auto-immune
|
WO2007035057A1
(fr)
|
2005-09-23 |
2007-03-29 |
Gwangju Institute Of Science And Technology |
Composition pour la prevention ou le traitement d'arthrite comportant des bacteries lactiques et du collagene en tant que principes actifs
|
EP1776877A1
(fr)
|
2005-10-21 |
2007-04-25 |
N.V. Nutricia |
Méthode de stimulation de la flore intestinale
|
AU2006306241B9
(en)
|
2005-10-24 |
2012-03-08 |
Nestec S.A. |
Dietary fiber formulation and method of administration
|
JP2007116991A
(ja)
|
2005-10-28 |
2007-05-17 |
Eternal Light General Institute Inc |
機能性食品
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
CA2632921A1
(fr)
|
2005-12-01 |
2007-06-07 |
Schering Corporation |
Composes pour le traitement de troubles inflammatoires et de maladies microbiennes
|
WO2007098371A2
(fr)
|
2006-02-16 |
2007-08-30 |
Wayne State University |
Utilisation de la flagelline dans la prévention et le traitement de l'infection par des bactéries à gram négatif
|
US20080260906A1
(en)
|
2006-03-17 |
2008-10-23 |
Marko Stojanovic |
Compositions comprising probiotic and sweetener components
|
JP5031249B2
(ja)
|
2006-03-22 |
2012-09-19 |
学校法人北里研究所 |
炎症抑制作用のある菌体含有組成物
|
WO2007136719A2
(fr)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Compositions thérapeutiques et leurs utilisations
|
CA2655665A1
(fr)
|
2006-05-26 |
2007-12-06 |
Nestec S.A. |
Procedes d'utilisation d'extrait de touchi et compositions nutritionnelles d'extrait de touchi associees
|
US20100028449A1
(en)
|
2006-06-06 |
2010-02-04 |
Satya Prakash |
Fermented milk product and use thereof
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
ES2525223T3
(es)
|
2006-08-04 |
2014-12-19 |
Shs International Ltd. |
Fórmula sin proteínas
|
WO2008031438A2
(fr)
|
2006-09-13 |
2008-03-20 |
Region Hovedstaden V/Gentofte Hospital |
Traitement de l'asthme, de l'eczéma et / ou d'allergies à l'aide d'organismes non pathogènes
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
ES2895666T3
(es)
|
2006-10-27 |
2022-02-22 |
Capsugel Belgium Nv |
Cápsulas duras de hidroxipropilmetilcelulosa y proceso de fabricación
|
US20080118473A1
(en)
|
2006-11-01 |
2008-05-22 |
The Procter & Gamble Company |
Methods of treating a respiratory condition comprising probiotic treatment
|
PL1920781T3
(pl)
|
2006-11-10 |
2015-06-30 |
Glycotope Gmbh |
Kompozycje zawierające core-1-dodatnie mikroorganizmy i ich zastosowanie w leczeniu lub profilaktyce nowotworów
|
WO2008064489A1
(fr)
|
2006-12-01 |
2008-06-05 |
Mcmaster University |
Probiotiques destinés à inhiber les inflammations
|
EP2102350A4
(fr)
|
2006-12-18 |
2012-08-08 |
Univ St Louis |
Microbiome intestinal en tant que biomarqueur et cible thérapeutique pour traiter l'obésité ou un trouble lié à l'obésité
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
WO2008083157A2
(fr)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altération du pgc-1alpha, de l'ampk, du fiaf, ou du microbiote gastro-intestinal comme moyen pour moduler les réserves lipidiques de l'organisme et/ou la perte de poids chez un sujet
|
JP2008195635A
(ja)
|
2007-02-09 |
2008-08-28 |
Crossfield Bio Inc |
馬用乳酸菌製剤
|
CA2679374C
(fr)
|
2007-02-28 |
2016-05-31 |
Mead Johnson Nutrition Company |
Procede de traitement ou de prevention d'une inflammation generalisee
|
AU2008231467A1
(en)
|
2007-03-28 |
2008-10-02 |
Alimentary Health Limited |
Probiotic Bifidobacterium strains
|
US8557233B2
(en)
|
2007-03-28 |
2013-10-15 |
Alimentary Heath Limited |
Probiotic bifidobacterium strains
|
WO2008134450A2
(fr)
|
2007-04-24 |
2008-11-06 |
Kemin Industries, Inc. |
Activité antibactérienne et antifongique à spectre large de lactobacillus johnsonii d115
|
EP1997499A1
(fr)
|
2007-05-31 |
2008-12-03 |
Puleva Biotech, S.A. |
Microorganismes de lait maternel, compositions les contenant et leur utilisation pour le traitement de métastase
|
EP1997906A1
(fr)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Lactobacillus
|
EP1997905A1
(fr)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Amplification d'acide nucléique
|
EP1997907A1
(fr)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Bifidobactéries
|
WO2008153377A1
(fr)
|
2007-06-15 |
2008-12-18 |
N.V. Nutricia |
Nutrition avec une bifidobactérie non viable et un oligosaccharide non digestible
|
WO2009002145A1
(fr)
|
2007-06-26 |
2008-12-31 |
N.V. Nutricia |
Composition lipidique destinée à améliorer l'activité cérébrale
|
ES2523575T3
(es)
|
2007-06-27 |
2014-11-27 |
Laboratorios Ordesa, S.L. |
Una nueva cepa de bifidobacterium y peptidos acitvos contra infecciones por rotavirus
|
HUP0700552A2
(en)
|
2007-08-27 |
2009-03-30 |
Janos Dr Feher |
Method and composition inhibiting inflammation
|
WO2009030254A1
(fr)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes d'arn et de peptides cationiques pour transfection et immunostimulation
|
US20100284979A1
(en)
|
2007-10-01 |
2010-11-11 |
University College Cork, National University Of Ireland, Cork |
Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria
|
ES2431572T3
(es)
|
2007-10-20 |
2013-11-27 |
Université de Liège |
Especies bifidobacterianas
|
NZ585210A
(en)
|
2007-10-26 |
2012-07-27 |
Brenda e moore |
Probiotic compositions comprising bacteroides and methods for inducing and supporting weight loss
|
EP2205642B1
(fr)
|
2007-11-02 |
2016-01-27 |
Momenta Pharmaceuticals, Inc. |
Compositions de polysaccharides non anticoagulants
|
EP2065048A1
(fr)
|
2007-11-30 |
2009-06-03 |
Institut Pasteur |
Utilisation d'une souche de L. casei pour la préparation d'une composition pour l'inhibition de l'activation de mastocytes
|
PL2356992T3
(pl)
|
2007-12-07 |
2018-01-31 |
Nutricia Nv |
Bifidobakteria na alergię na roztocza kurzu
|
US20100330190A1
(en)
|
2007-12-17 |
2010-12-30 |
Compans Richard W |
Immunogenic compositions and methods of use thereof
|
ES2343499B1
(es)
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
AU2009212295A1
(en)
|
2008-02-06 |
2009-08-13 |
The Procter & Gamble Company |
Compositions methods and kits for enhancing immune response to a respiratory condition
|
EP2103226A1
(fr)
|
2008-03-18 |
2009-09-23 |
Friesland Brands B.V. |
Produit alimentaire probiotique de longue durée
|
JP2011519828A
(ja)
|
2008-04-18 |
2011-07-14 |
バクシネート コーポレーション |
フラジェリンの欠失変異体と使用方法
|
JP2011520435A
(ja)
|
2008-05-13 |
2011-07-21 |
グリコトープ ゲーエムベーハー |
発酵プロセス
|
MX2008006546A
(es)
|
2008-05-21 |
2009-11-23 |
Sigma Alimentos Sa De Cv |
Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
CN101590081A
(zh)
|
2008-05-28 |
2009-12-02 |
青岛东海药业有限公司 |
凸腹真杆菌和两形真杆菌制剂及其应用
|
US8586029B2
(en)
|
2008-06-04 |
2013-11-19 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
CN101596216A
(zh)
*
|
2008-06-06 |
2009-12-09 |
萧湘 |
预防或治疗糖尿病和相关病症的微生物制剂
|
EP2133088A3
(fr)
|
2008-06-09 |
2010-01-27 |
Nestec S.A. |
Rooibos et inflammation
|
WO2009151315A1
(fr)
|
2008-06-13 |
2009-12-17 |
N.V. Nutricia |
Composition nutritionnelle pour nourrissons nés par césarienne
|
WO2009154463A2
(fr)
|
2008-06-20 |
2009-12-23 |
Stichting Top Institute Food And Nutrition |
Le butyrate comme médicament permettant d'améliorer la perception viscérale chez l'homme
|
EP2138186A1
(fr)
|
2008-06-24 |
2009-12-30 |
Nestec S.A. |
Probiotiques, IgA de sécrétion et inflammation
|
WO2010002241A1
(fr)
|
2008-06-30 |
2010-01-07 |
N.V. Nutricia |
Composition nutritive pour bébés nés par césarienne
|
KR101017448B1
(ko)
|
2008-09-18 |
2011-02-23 |
주식회사한국야쿠르트 |
대장의 건강 증진 효능을 갖는 비피도박테리움 롱검 에이취와이8004 및 이를 유효성분으로 함유하는 제품
|
US8137718B2
(en)
|
2008-09-19 |
2012-03-20 |
Mead Johnson Nutrition Company |
Probiotic infant products
|
US20100074870A1
(en)
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
US9603876B2
(en)
|
2008-09-25 |
2017-03-28 |
New York University |
Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
|
WO2010037408A1
(fr)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprenant un arnm complexé et un arnm nu pour déclencher ou augmenter une réponse immunostimulante chez un mammifère et utilisations de ladite composition
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
BRPI0922296A2
(pt)
|
2008-12-05 |
2015-08-11 |
Nestec Sa |
Composições para o uso em recém-nascidos com baixo peso no nascimento.
|
RU2011129812A
(ru)
|
2008-12-19 |
2013-01-27 |
Нестек С.А. |
Профилактика и лечение ротавирусной диареи
|
IT1392672B1
(it)
|
2009-01-12 |
2012-03-16 |
Wyeth Consumer Healthcare S P A |
Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
|
NZ611324A
(en)
|
2009-03-05 |
2015-02-27 |
Abbvie Inc |
Il-17 binding proteins
|
JP5710876B2
(ja)
|
2009-03-26 |
2015-04-30 |
クロスフィールドバイオ株式会社 |
新規ビフィドバクテリウム属微生物およびその利用
|
US8816067B2
(en)
|
2009-05-07 |
2014-08-26 |
Tate & Lyle Ingredients France SAS |
Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
|
MX338680B
(es)
|
2009-05-11 |
2016-04-27 |
Nestec Sa |
Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
|
EP2251022A1
(fr)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Micro-organismes sans réplication, et leur effet d'augmentation immunitaire
|
EP2251020A1
(fr)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Traitement haute température de courte durée qui génère des préparations microbiennes avec des profils anti-inflammatoires
|
KR20100128168A
(ko)
|
2009-05-27 |
2010-12-07 |
중앙대학교 산학협력단 |
공액 리놀레산 생산능이 우수한 신규한 균주
|
US20100311686A1
(en)
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
WO2010143940A1
(fr)
|
2009-06-12 |
2010-12-16 |
N.V. Nutricia |
Mélange synergique de bêta-galacto-oligosaccharides avec des liaisons bêta-1,3 et bêta-1,4/1,6
|
US9050276B2
(en)
*
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
WO2010147714A1
(fr)
|
2009-06-16 |
2010-12-23 |
The Trustees Of Columbia University In The City Of New York |
Biomarqueurs associés à l'autisme et utilisations de ces derniers
|
WO2011005756A1
(fr)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Administration d'agents ciblés contre des niches de microbiote
|
US20120129794A1
(en)
|
2009-07-24 |
2012-05-24 |
Dowd Scot E |
Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
|
MY163002A
(en)
|
2009-08-18 |
2017-07-31 |
Nestec Sa |
A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
GB2473294B
(en)
|
2009-09-08 |
2014-07-09 |
Mclaren Automotive Ltd |
Dynamics control
|
WO2011036539A1
(fr)
|
2009-09-23 |
2011-03-31 |
Borody Thomas J |
Thérapie pour infections entériques
|
EP2308498A1
(fr)
|
2009-09-30 |
2011-04-13 |
Nestec S.A. |
Administration de bifidobacterium rapide au cours de l'enfance pour empêcher une inflammation postérieure au cours de la vie
|
EP2486143A1
(fr)
|
2009-10-05 |
2012-08-15 |
AAK Patent B.V. |
Procédé de diagnostic du syndrome du côlon irritable
|
EP2485742A4
(fr)
|
2009-10-06 |
2013-03-20 |
Scott Dorfner |
Formulations antibiotiques exerçant des effets secondaires gastro-intestinaux réduits
|
AU2010317422A1
(en)
|
2009-11-11 |
2012-05-31 |
Alimentary Health Limited |
Probiotic Bifidobacterium strain
|
MY162183A
(en)
|
2009-12-01 |
2017-05-31 |
Univ Putra Malaysia |
Probiotic composition for nutraceutical product
|
BR112012013571A2
(pt)
|
2009-12-18 |
2015-09-15 |
Hills Pet Nutrition Inc |
composições alimentares para animais de estimação,incluindo probióticos e os métodos de fabricação e á sua uitlização.
|
JP5557520B2
(ja)
|
2009-12-22 |
2014-07-23 |
京楽産業.株式会社 |
遊技機の演出用動力伝達機構及びこれを備える遊技機
|
US20150104418A1
(en)
|
2014-12-18 |
2015-04-16 |
Microbios, Inc. |
Bacterial composition
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
NL2004201C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides to modulate the immune system.
|
NL2004200C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides in weight management.
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
JP5737646B2
(ja)
|
2010-03-24 |
2015-06-17 |
森下仁丹株式会社 |
抗アレルギー剤
|
WO2011121379A1
(fr)
|
2010-03-30 |
2011-10-06 |
Assistance Publique - Hopitaux De Paris |
Utilisation de bifidobactéries pour prévenir les allergies chez les enfants nourris au sein
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
WO2011149335A1
(fr)
|
2010-05-25 |
2011-12-01 |
N.V. Nutricia |
Composition nutritionnelle d'empreinte immunitaire
|
CA2836413A1
(fr)
|
2010-06-01 |
2011-12-08 |
Moore Research Enterprises Llc |
Constituants cellulaires issus de bacteries du genre bacteroides, compositions en contenant et methodes therapeutiques utilisant des bacteries du genre bacteroides ou des constituants cellulaires de celles-ci
|
WO2011151941A1
(fr)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
Composition présentant une activité d'induction de la prolifération ou de l'accumulation de cellule t régulatrice
|
TWI417054B
(zh)
|
2010-06-15 |
2013-12-01 |
Jen Shine Biotechnology Co Ltd |
新穎糞腸球菌ljs-01及其益生用途
|
EP2397145A1
(fr)
|
2010-06-18 |
2011-12-21 |
Nestec S.A. |
L. johnsonii La1, B. longum NCC2705 et troubles immunitaires
|
FR2962045B1
(fr)
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
CN101914452B
(zh)
*
|
2010-07-14 |
2011-12-07 |
洪亚辉 |
石杉碱甲高产菌株tcm-01
|
TWI401086B
(zh)
|
2010-07-20 |
2013-07-11 |
Univ China Medical |
胚芽乳酸桿菌及其用途
|
CA2804709A1
(fr)
|
2010-07-26 |
2012-02-02 |
Qu Biologics Inc. |
Compositions anti-inflammatoires immunogenes
|
CN103124559B
(zh)
|
2010-08-04 |
2017-03-29 |
托马斯·朱利叶斯·波洛迪 |
用于粪便菌群植入的组合物及其制备和使用方法以及递送该组合物的装置
|
US9386793B2
(en)
|
2010-08-20 |
2016-07-12 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
KR101250463B1
(ko)
|
2010-10-12 |
2013-04-15 |
대한민국 |
신생아 분변에서 분리한 내산소성 비피도박테리움 롱검 비피더스 유산균 및 이를 이용한 프로바이오틱 조성물
|
CA2815259A1
(fr)
|
2010-10-27 |
2012-05-03 |
Quantibact A/S |
Capture d'adn et d'arn cibles par des sondes comprenant des molecules intercalaires
|
CN102031235B
(zh)
|
2010-11-09 |
2012-07-25 |
中国农业大学 |
一种粪肠球菌anse228及其应用
|
EP2455092A1
(fr)
|
2010-11-11 |
2012-05-23 |
Nestec S.A. |
Protection de micro-organismes probiotiques sans réplication contre les infections des voies respiratoires supérieures
|
US20120128644A1
(en)
|
2010-11-24 |
2012-05-24 |
Oragenics, Inc. |
Use of Bacteria to Treat and Prevent Respiratory Infections
|
CN102093967B
(zh)
|
2010-12-02 |
2013-01-30 |
中国农业科学院特产研究所 |
一株水貂源屎肠球菌及其应用
|
ES2389547B1
(es)
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
AU2012205681B2
(en)
|
2011-01-10 |
2016-07-28 |
Cleveland Biolabs, Inc. |
Use of toll-like receptor agonist for treating cancer
|
HUE033189T2
(en)
|
2011-01-31 |
2017-11-28 |
Synformulas Gmbh |
Bifidobacterium bifidum strains for use in gastrointestinal disorders
|
JP5840368B2
(ja)
|
2011-02-02 |
2016-01-06 |
カルピス株式会社 |
関節炎予防改善用物質
|
CN103491969A
(zh)
|
2011-02-09 |
2014-01-01 |
拉维沃公司 |
恢复和重建肠道微生物群的合生素组合物
|
CN103561752B
(zh)
|
2011-03-09 |
2016-04-20 |
明尼苏达大学评议会 |
用于移植结肠微生物群的组合物和方法
|
BRPI1100857A2
(pt)
|
2011-03-18 |
2013-05-21 |
Alexandre Eduardo Nowill |
agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
|
WO2012140636A1
(fr)
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
Formulation probiotique
|
WO2012142605A1
(fr)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Agent de déploiement de recolonisation rapide
|
CA2833633A1
(fr)
|
2011-04-20 |
2012-10-26 |
Jason Fisher |
Composition et procede pour augmenter une reponse immunitaire
|
US9567361B2
(en)
|
2011-05-13 |
2017-02-14 |
Glycosyn LLC |
Use of purified 2′-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
|
KR20120133133A
(ko)
|
2011-05-30 |
2012-12-10 |
한국 한의학 연구원 |
생약 추출물 또는 이의 유산균 발효물을 포함하는 호흡기 질환의 예방 또는 치료용 조성물
|
WO2012170478A2
(fr)
|
2011-06-06 |
2012-12-13 |
The University Of North Carolina At Chapel Hill |
Procédés et trousses pour la détection d'adénomes, d'un cancer colorectal, et leurs utilisations
|
GB201110095D0
(en)
|
2011-06-15 |
2011-07-27 |
Danisco |
Method of treatment
|
US9579353B2
(en)
*
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
JP2013005759A
(ja)
|
2011-06-24 |
2013-01-10 |
Kyodo Milk Industry Co Ltd |
マウス腸内菌叢の推測方法
|
CN102408998B
(zh)
*
|
2011-06-28 |
2013-06-05 |
深圳大学 |
一种具有神经退行性疾病防治活性的海洋红树耐盐性内生真菌
|
WO2013005836A1
(fr)
|
2011-07-07 |
2013-01-10 |
長岡香料株式会社 |
Inhibiteur d'absorption de fructose
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
WO2013008102A2
(fr)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Procédés et compositions pour évaluer et/ou traiter des maladies immunitaires chroniques
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
CN102304483A
(zh)
|
2011-08-12 |
2012-01-04 |
北京金泰得生物科技股份有限公司 |
一株饲用屎肠球菌及其应用
|
KR101261872B1
(ko)
|
2011-08-23 |
2013-05-14 |
대한민국 (식품의약품안전처장) |
장내 미생물 효소복합체 및 이의 제조방법
|
WO2013037067A1
(fr)
|
2011-09-14 |
2013-03-21 |
University Of Guelph |
Compléments de milieu et procédés de culture de microorganismes anaérobies gastro-intestinaux humains
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
DK2750682T3
(en)
|
2011-10-11 |
2016-08-22 |
Achim Biotherapeutics Ab |
A composition comprising anaerobically cultured human intestinal flora
|
FI126711B
(fi)
|
2011-10-12 |
2017-04-13 |
Gut Guide Oy |
Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
|
CN103082292B
(zh)
|
2011-11-02 |
2015-03-04 |
深圳华大基因研究院 |
罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用
|
CN102373172B
(zh)
|
2011-11-03 |
2013-03-20 |
北京龙科方舟生物工程技术有限公司 |
一株屎肠球菌及其应用
|
CN108676774B
(zh)
|
2011-12-01 |
2023-05-09 |
国立大学法人东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
ES2408279B1
(es)
|
2011-12-15 |
2014-09-09 |
Universidad De Las Palmas De Gran Canaria |
Bacteria acido láctica probiótica
|
ITBG20120010A1
(it)
|
2012-02-24 |
2013-08-25 |
Milano Politecnico |
Dispositivo per l'addestramento chirurgico
|
ITMI20120471A1
(it)
|
2012-03-26 |
2013-09-27 |
Giovanni Mogna |
Composizione a base di ceppi di batteri bifidobacterium longum in grado di aiutare il prolungamento della vita
|
JP5792105B2
(ja)
|
2012-03-27 |
2015-10-07 |
森永乳業株式会社 |
ラクト−n−ビオースiの製造方法
|
WO2013146319A1
(fr)
|
2012-03-30 |
2013-10-03 |
味の素株式会社 |
Bactérie induisant le diabète
|
US20130280724A1
(en)
|
2012-04-11 |
2013-10-24 |
Nestec Sa |
Methods for diagnosing impending diarrhea
|
GB201206599D0
(en)
|
2012-04-13 |
2012-05-30 |
Univ Manchester |
Probiotic bacteria
|
EP2836218A4
(fr)
|
2012-04-13 |
2015-10-21 |
Trustees Boston College |
Compositions prébiotiques et leurs procédés d'utilisation
|
US10130665B2
(en)
|
2012-05-18 |
2018-11-20 |
Genome Research Limited |
Method for identifying bacteria for bacteriotherapy
|
ES2436251B1
(es)
|
2012-05-25 |
2014-10-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
|
AU2013271336B2
(en)
|
2012-06-04 |
2017-11-30 |
Centre For Digestive Diseases |
Compositions and methods for treating Crohn's Disease and related conditions and infections
|
CN106620189B
(zh)
|
2012-06-06 |
2021-11-19 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
WO2014001368A1
(fr)
|
2012-06-25 |
2014-01-03 |
Orega Biotech |
Anticorps antagonistes de l'il-17
|
CN104582506B
(zh)
|
2012-07-31 |
2016-10-19 |
雀巢产品技术援助有限公司 |
用于促进患有炎症性肠病(ibd)的患者的肌肉骨骼健康的营养组合物
|
US20150211053A1
(en)
|
2012-08-01 |
2015-07-30 |
Bgi-Shenzhen |
Biomarkers for diabetes and usages thereof
|
KR101426276B1
(ko)
*
|
2012-08-16 |
2014-08-05 |
주식회사한국야쿠르트 |
심장질환 및 뇌졸중을 유발하는 거품세포 형성 억제 및 혈관 병변 형성을 억제하는 활성을 가지는 락토바실러스 플란타룸 hy7712를 유효성분으로 함유하는 제품
|
US10874701B2
(en)
|
2012-08-16 |
2020-12-29 |
University-Industry Cooperation Group Of Kyung Hee University |
Lactic acid bacteria capable of preventing and/or treating senescence and dementia
|
BR112015004165A2
(pt)
|
2012-08-29 |
2017-07-04 |
Salix Pharmaceuticals Inc |
métodos e composições laxantes para o tratamento de constipação e condições e doenças gastrointestinais relacionadas
|
JP6679309B2
(ja)
|
2012-08-29 |
2020-04-15 |
カリフォルニア インスティチュート オブ テクノロジー |
自閉症スペクトラム障害の診断および処置
|
CA2884816A1
(fr)
|
2012-09-13 |
2014-03-20 |
Massachusetts Institute Of Technology |
Profils d'administration de medicaments programmables de bacteries ciblees par une tumeur
|
KR101473058B1
(ko)
|
2012-09-19 |
2014-12-16 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
CN103652322B
(zh)
|
2012-09-21 |
2016-02-10 |
临沂思科生物科技有限公司 |
一种含乳酸菌的复合益生菌饲料添加剂的制备方法
|
EP3401396A1
(fr)
|
2012-10-03 |
2018-11-14 |
Metabogen AB |
Traitement ou prevention de l'athérosclérose ou maladies associées par le bêta-carotène
|
FR2997091B1
(fr)
|
2012-10-22 |
2016-05-06 |
Fond Mediterranee Infection |
Utilisation d'un compose antioxydant pour la culture de bacteries sensibles a la tension en oxygene
|
EP2914275A1
(fr)
|
2012-10-30 |
2015-09-09 |
Nestec S.A. |
Compositions comprenant des microparticules et des probiotiques permettant d'apporter un effet immunitaire synergique
|
US9839657B2
(en)
|
2012-10-30 |
2017-12-12 |
Deerland Enzymes, Inc. |
Prebiotic compositions comprising one or more types of bacteriophage
|
WO2014070014A1
(fr)
|
2012-11-01 |
2014-05-08 |
Rijksuniversiteit Groningen |
Procédés et compositions pour la stimulation de bactéries bénéfiques dans le tractus gastro-intestinal
|
WO2014075745A1
(fr)
|
2012-11-19 |
2014-05-22 |
Université Catholique de Louvain |
Utilisation d'akkermansia pour le traitement de troubles métaboliques
|
DK3628161T3
(da)
|
2012-11-23 |
2023-05-30 |
Seres Therapeutics Inc |
Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
BR112015012123A8
(pt)
|
2012-11-26 |
2018-01-23 |
Borody Thomas J |
composições para a recuperação de uma microbiota fecal e métodos para produzir e usar as mesmas.
|
DK2931897T3
(en)
|
2012-12-12 |
2018-02-05 |
Broad Inst Inc |
CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS
|
IL300461A
(en)
|
2012-12-12 |
2023-04-01 |
Harvard College |
Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
|
PL2931898T3
(pl)
|
2012-12-12 |
2016-09-30 |
Le Cong |
Projektowanie i optymalizacja systemów, sposoby i kompozycje do manipulacji sekwencją z domenami funkcjonalnymi
|
US20140193464A1
(en)
|
2013-01-08 |
2014-07-10 |
Imagilin Technology, Llc |
Effects of probiotics on humans and animals under environmental or biological changes
|
MX369877B
(es)
|
2013-02-04 |
2019-11-25 |
Seres Therapeutics Inc |
Composiciones y metodos.
|
WO2014121304A1
(fr)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions et procédés
|
AU2014219048B2
(en)
|
2013-02-22 |
2018-12-13 |
The Regents Of The University Of California |
Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
|
JP2016511272A
(ja)
|
2013-03-05 |
2016-04-14 |
レイクスユニフェルシテイト フローニンゲン |
炎症を抑制するためのフィーカリバクテリウム・パラウスニッチィーhtf−f(dsm26943)の使用
|
WO2014153194A2
(fr)
|
2013-03-14 |
2014-09-25 |
Seres Health, Inc. |
Procédés de détection de pathogènes et d'enrichissement à partir de matériaux et de compositions
|
CA3101218A1
(fr)
|
2013-03-14 |
2014-09-25 |
Therabiome, Llc |
Administration ciblee d'organismes probiotiques et/ou d'agents therapeutiques dans le tractus gastro-intestinal
|
AU2014232370B2
(en)
|
2013-03-15 |
2018-11-01 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
WO2014150094A1
(fr)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Bactéries butyrogènes en tant que probiotiques pour le traitement de clostridium difficile
|
WO2014150139A1
(fr)
|
2013-03-15 |
2014-09-25 |
Microbiome Therapeutics, Llc. |
Fibre de cosse de soja activée
|
CN103142656A
(zh)
|
2013-03-18 |
2013-06-12 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备防治结肠癌组合物中的应用
|
CN103156888A
(zh)
|
2013-03-18 |
2013-06-19 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备治疗炎症性肠病组合物中的应用
|
CN103146620A
(zh)
|
2013-03-25 |
2013-06-12 |
广州知光生物科技有限公司 |
具有益生菌特性的脆弱拟杆菌
|
JP2014196260A
(ja)
|
2013-03-29 |
2014-10-16 |
公立大学法人奈良県立医科大学 |
慢性閉塞性肺疾患の予防又は治療用組成物
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
EP2994161B1
(fr)
|
2013-05-10 |
2020-10-28 |
California Institute of Technology |
Prévention et traitement probiotiques du cancer du côlon
|
JP6079876B2
(ja)
|
2013-05-31 |
2017-02-15 |
日本電気株式会社 |
分散処理システム
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
EP3003330B1
(fr)
|
2013-06-05 |
2018-05-09 |
Rebiotix, Inc. |
Compositions de thérapie de rétablissement de microbiote (mrt) et procédés de fabrication
|
US20160120915A1
(en)
|
2013-06-10 |
2016-05-05 |
New York University |
Methods for manipulating immune responses by altering microbiota
|
WO2014200334A1
(fr)
|
2013-06-14 |
2014-12-18 |
N.V. Nutricia |
Composition synbiotique pour le traitement d'infections chez des patients allergiques
|
WO2015003001A1
(fr)
|
2013-07-01 |
2015-01-08 |
The Washington University |
Procédés pour identifier des compléments qui augmentent la colonisation intestinale par une espèce bactérienne isolée, et compositions dérivées
|
WO2015003305A1
(fr)
|
2013-07-08 |
2015-01-15 |
吉瑞高新科技股份有限公司 |
Étui de cigarette électronique
|
US9764019B2
(en)
|
2013-07-09 |
2017-09-19 |
Vedanta Biosciences, Inc. |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
US10633714B2
(en)
|
2013-07-21 |
2020-04-28 |
Pendulum Therapeutics, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
EP3027058B1
(fr)
|
2013-07-31 |
2020-07-15 |
Incredible Foods, Inc. |
Compositions d'aliment fonctionnel enrobé
|
CN105658226B
(zh)
|
2013-08-16 |
2019-05-14 |
港大科桥有限公司 |
使用益生菌治疗癌症的方法和组合物
|
CN103509741B
(zh)
|
2013-08-22 |
2015-02-18 |
河北农业大学 |
布劳特菌auh-jld56及其在牛蒡苷元转化中的应用
|
CN104415060A
(zh)
|
2013-08-30 |
2015-03-18 |
深圳华大基因科技有限公司 |
可食用组合物及其制备方法和用途
|
ITMI20131467A1
(it)
|
2013-09-06 |
2015-03-07 |
Sofar Spa |
Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
|
US10203329B2
(en)
|
2013-09-12 |
2019-02-12 |
The Johns Hopkins University |
Biofilm formation to define risk for colon cancer
|
US10058576B2
(en)
|
2013-10-03 |
2018-08-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods comprising a defined microbiome and methods of use thereof
|
WO2015057151A1
(fr)
|
2013-10-18 |
2015-04-23 |
Innovafood Ab |
Repas composite équilibré au plan nutritionnel pour nourrissons et petits enfants et procédé de production dudit repas
|
PL229020B1
(pl)
|
2013-11-13 |
2018-05-30 |
Inst Biotechnologii Surowic I Szczepionek Biomed Spolka Akcyjna |
Nowy szczep Bifidobacterium breve
|
KR102379658B1
(ko)
|
2013-11-25 |
2022-03-28 |
세레스 테라퓨틱스, 인코포레이티드 |
상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
|
WO2015095241A2
(fr)
|
2013-12-16 |
2015-06-25 |
Seres Health, Inc. |
Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire
|
CN103981115B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其应用
|
CN103981117B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其培养方法和应用
|
CN103820363B
(zh)
|
2014-01-27 |
2016-02-24 |
福建省农业科学院生物技术研究所 |
一种屎肠球菌菌粉的制备与应用
|
CN103865846B
(zh)
|
2014-02-27 |
2016-03-30 |
扬州绿保生物科技有限公司 |
一种屎肠球菌及其制备方法
|
CN103849590B
(zh)
|
2014-03-25 |
2016-07-06 |
上海交通大学 |
一株耐酸短双歧杆菌BB8dpH及其应用
|
KR101683474B1
(ko)
|
2014-03-26 |
2016-12-08 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
US9783858B2
(en)
|
2014-04-02 |
2017-10-10 |
Northwestern University |
Altered microbiome of chronic pelvic pain
|
KR101583546B1
(ko)
|
2014-04-09 |
2016-01-11 |
국립암센터 |
유전자 다형성을 이용한 소라페닙 치료에 대한 반응성 예측방법
|
EP3129035A4
(fr)
|
2014-04-10 |
2018-03-28 |
Riken |
Compositions et méthodes d'induction de cellules th17
|
CN104195075B
(zh)
|
2014-08-14 |
2017-04-19 |
生合生物科技股份有限公司 |
一种屎肠球菌ef08及包含它的饲料添加物和饲料
|
WO2015168534A1
(fr)
|
2014-05-02 |
2015-11-05 |
Novogy, Inc. |
Traitement thérapeutique de déséquilibres microbiens gastro-intestinaux par déplacement de microbes compétitif
|
AU2015257651B2
(en)
|
2014-05-08 |
2020-01-23 |
Panoptes Pharma Ges.M.B.H. |
Compounds for treating ophthalmic diseases and disorders
|
CN106573044B
(zh)
|
2014-08-05 |
2020-01-21 |
深圳华大基因科技有限公司 |
真杆菌属在预防和治疗结直肠癌相关疾病中的用途
|
CN106687130B
(zh)
|
2014-08-05 |
2020-01-21 |
深圳华大基因科技有限公司 |
真杆菌属在预防和治疗结直肠癌相关疾病中的用途
|
US10925953B2
(en)
|
2014-08-28 |
2021-02-23 |
Yale University |
Compositions and methods for treating an inflammatory disease or disorder
|
WO2016036615A1
(fr)
|
2014-09-03 |
2016-03-10 |
California Institute Of Technology |
Modulation à base microbienne de la biosynthèse de la sérotonine
|
CN104546932A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
卵形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546935A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546942A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多氏拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546940A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
平常拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546933A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
粪拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546934B
(zh)
|
2014-09-30 |
2019-04-09 |
深圳华大基因科技有限公司 |
粪副拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
US10046030B2
(en)
|
2014-10-07 |
2018-08-14 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating infection
|
MX2017005260A
(es)
|
2014-10-24 |
2018-01-30 |
Evolve Biosystems Inc |
Bifidobacterias activadas y metodos de uso de las mismas.
|
WO2016069801A1
(fr)
|
2014-10-30 |
2016-05-06 |
California Institute Of Technology |
Compositions et procédés comprenant des bactéries pour améliorer le comportement dans les troubles neurodéveloppementaux
|
WO2016069795A2
(fr)
|
2014-10-30 |
2016-05-06 |
California Institute Of Technology |
Compositions et procédés comprenant des bactéries pour l'amélioration du comportement dans les troubles neurodéveloppementaux
|
EP3881680A1
(fr)
|
2014-10-31 |
2021-09-22 |
Pendulum Therapeutics, Inc. |
Procédés et compositions se rapportant à un traitement microbien de troubles
|
CN104435000A
(zh)
|
2014-11-12 |
2015-03-25 |
江南大学 |
乳酸菌对支气管哮喘治疗中的应用
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
JP6777643B2
(ja)
|
2014-11-25 |
2020-10-28 |
メモリアル スローン ケタリング キャンサー センター |
腸内微生物叢及びgvhd
|
SI3193901T1
(en)
|
2014-12-23 |
2018-06-29 |
4D Pharma Research Limited |
Pirin polypeptide and immune modulation
|
NO3065748T3
(fr)
|
2014-12-23 |
2018-04-21 |
|
|
CN104560820B
(zh)
|
2014-12-30 |
2017-10-20 |
杭州师范大学 |
屎肠球菌kq2.6及应用
|
US20160199425A1
(en)
*
|
2015-01-08 |
2016-07-14 |
Nubiome, Inc. |
Treatment and Prophylaxis for Parkinson's Disease
|
EP3247342A4
(fr)
|
2015-01-23 |
2018-10-10 |
Temple University - Of The Commonwealth System of Higher Education |
Utilisation d'acides gras à chaîne courte dans la prévention du cancer
|
CN105982919A
(zh)
|
2015-02-26 |
2016-10-05 |
王汉成 |
生物减速剂抗癌技术
|
WO2016139217A1
(fr)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprenant un microbiote intestinal humain cultivé en conditions anaérobies
|
GB2553701A
(en)
|
2015-03-18 |
2018-03-14 |
Whole Biome Inc |
Methods and compositions relating to microbial treatment and diagnosis of skin disorders
|
US20180078587A1
(en)
|
2015-03-18 |
2018-03-22 |
Trustees Of Tufts College |
Compositions and methods for preventing colorectal cancer
|
KR101745084B1
(ko)
|
2015-05-06 |
2017-06-09 |
한양대학교 산학협력단 |
메가스페라 헥사노이카 균주를 이용하여 헥사노익산을 생산하는 방법
|
KR20160131237A
(ko)
*
|
2015-05-06 |
2016-11-16 |
한양대학교 산학협력단 |
C5-c8 유기산을 생산하는 신규 균주 및 이를 이용하여 c5-c8 유기산을 생산하는 방법
|
EP3303401A4
(fr)
|
2015-06-01 |
2018-12-26 |
The University of Chicago |
Traitement du cancer par manipulation de la flore microbienne commensale
|
HUE045754T2
(hu)
|
2015-06-15 |
2020-01-28 |
4D Pharma Res Ltd |
Blautia stercosis és wexlerae gyulladásos és autoimmun betegségek kezelésében történõ alkalmazásra
|
PT3206700T
(pt)
|
2015-06-15 |
2019-08-21 |
4D Pharma Res Ltd |
Composições compreendendo estirpes bacterianas
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
CN107847529B
(zh)
|
2015-06-15 |
2022-05-03 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
WO2017031371A1
(fr)
|
2015-08-20 |
2017-02-23 |
Api Holdings, Llc |
Formulations et procédés pour favoriser la santé de l'abeille à miel
|
CN105112333A
(zh)
|
2015-08-31 |
2015-12-02 |
江南大学 |
一种具有良好肠道定殖能力的长双歧杆菌及筛选方法和应用
|
EP4066846A1
(fr)
|
2015-11-03 |
2022-10-05 |
The Brigham & Women's Hospital, Inc. |
Microbiote thérapeutique pour le traitement et/ou la prévention de l'allergie alimentaire
|
HUE036362T2
(hu)
|
2015-11-20 |
2018-07-30 |
4D Pharma Res Ltd |
Baktériumtörzseket tartalmazó készítmények
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
PT3380108T
(pt)
|
2015-11-24 |
2023-02-17 |
Seres Therapeutics Inc |
Composições bacterianas concebidas
|
EP3379935A4
(fr)
|
2015-11-25 |
2019-08-28 |
Memorial Sloan-Kettering Cancer Center |
Procédés et compositions pour réduire une infection ou colonisation d'enterococci
|
US20190169586A1
(en)
|
2016-01-11 |
2019-06-06 |
3Plw Ltd. |
Lactic acid-utilizing bacteria genetically modified to secrete polysaccharide-degrading enzymes
|
PL3313423T3
(pl)
|
2016-03-04 |
2019-09-30 |
4D Pharma Plc |
Kompozycje zawierające szczepy bakteryjne blautia do leczenia nadwrażliwości trzewnej
|
US11116804B2
(en)
|
2016-03-14 |
2021-09-14 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
US9999641B2
(en)
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
JP6898628B2
(ja)
|
2016-06-15 |
2021-07-07 |
国立大学法人広島大学 |
神経変性疾患治療剤
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
IT201600091033A1
(it)
|
2016-09-08 |
2018-03-08 |
Bioimmunizer Sagl |
Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
|
EP3541400A2
(fr)
|
2016-11-18 |
2019-09-25 |
Sanford Burnham Prebys Medical Discovery Institute |
Microbiote intestinal et traitement du cancer
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2018112365A2
(fr)
|
2016-12-16 |
2018-06-21 |
Evelo Biosciences, Inc. |
Procédés de traitement du cancer colorectal et d'un mélanome en utilisant parabacteroides goldsteinii
|
US20190314427A1
(en)
|
2016-12-16 |
2019-10-17 |
Evelo Biosciences, Inc. |
Methods of treating cancer using parabacteroides
|
CN106890196A
(zh)
|
2017-04-07 |
2017-06-27 |
青岛东海药业有限公司 |
酪酸梭菌在制备预防或治疗帕金森病制剂中的应用
|
WO2018215782A1
(fr)
|
2017-05-24 |
2018-11-29 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
AU2018283994B2
(en)
|
2017-06-14 |
2021-03-18 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
PT3600363T
(pt)
|
2017-06-14 |
2021-02-03 |
4D Pharma Res Ltd |
Composições compreendendo estirpes bacterianas
|
AR112328A1
(es)
|
2017-07-05 |
2019-10-16 |
Evelo Biosciences Inc |
Composiciones y métodos para tratamiento de cáncer usando bifidobacterium animalis ssp. lactis
|
EP4066845A1
(fr)
|
2018-05-11 |
2022-10-05 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
JP2022513790A
(ja)
|
2018-12-12 |
2022-02-09 |
フォーディー ファーマ リサーチ リミテッド |
細菌株を含む組成物
|